Key result
Thrombolytic agents have been developed and evaluated over the past two decades for the treatment of thrombotic vascular occlusive syndromes, including acute myocardial infarction.
Provides a historical overview of the development and clinical application of thrombolytic agents for acute coronary syndromes and other thrombotic vascular occlusive syndromes.
No takes yet. Share an insight, caveat, or question.
Review of thrombolytic development contextualizes ACS care; leaves open questions on optimal contemporary applications.
Hanna et al. (1998) conducted a review in Coronary artery disease and thrombotic vascular occlusive syndromes. Thrombolytic agents was evaluated. Thrombolytic agents have been developed and evaluated over the past two decades for the treatment of thrombotic vascular occlusive syndromes, including acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: